Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Claire Drolen"'
Publikováno v:
Life, Vol 12, Iss 3, p 360 (2022)
Numerous immunotherapeutic agents, such as immune checkpoint inhibitors (ICIs), have been approved for the treatment of genitourinary (GU) malignancies. While ICIs have improved treatment outcomes and expanded treatment options, they can cause immune
Externí odkaz:
https://doaj.org/article/6089f5302b7a4e3db89aaf6feafd2194
Publikováno v:
Life, Vol 12, Iss 1, p 24 (2021)
Introduction: Renal cell carcinomas (RCC) have been treated with immunotherapy for decades; the use of immune checkpoint inhibitors represents the most recent advance. In this review, we compare these new RCC immunotherapies, with a focus on achievin
Externí odkaz:
https://doaj.org/article/fd4f4574a8cb46d889e534c2e2c4be69
Autor:
Talal El Zarif, Amin H. Nassar, Elio Adib, Bailey G. Fitzgerald, Jiaming Huang, Tarek H. Mouhieddine, Paul G. Rubinstein, Taylor Nonato, Rana R. McKay, Mingjia Li, Arjun Mittra, Dwight H. Owen, Robert A. Baiocchi, Michael Lorentsen, Christopher Dittus, Nazli Dizman, Adewunmi Falohun, Noha Abdel-Wahab, Adi Diab, Anand Bankapur, Alexandra Reed, Chul Kim, Aakriti Arora, Neil J. Shah, Edward El-Am, Elie Kozaily, Wassim Abdallah, Ahmad Al-Hader, Batool Abu Ghazal, Anwaar Saeed, Claire Drolen, Melissa G. Lechner, Alexandra Drakaki, Javier Baena, Caroline A. Nebhan, Tarek Haykal, Michael A. Morse, Alessio Cortellini, David J. Pinato, Alessia Dalla Pria, Evan Hall, Veli Bakalov, Nathan Bahary, Aarthi Rajkumar, Ankit Mangla, Vishal Shah, Parminder Singh, Frank Aboubakar Nana, Nerea Lopetegui-Lia, Danai Dima, Ryan W. Dobbs, Pauline Funchain, Rabia Saleem, Rachel Woodford, Georgina V. Long, Alexander M. Menzies, Carlo Genova, Giulia Barletta, Sonam Puri, Vaia Florou, Dame Idossa, Maristella Saponara, Paola Queirolo, Giuseppe Lamberti, Alfredo Addeo, Melissa Bersanelli, Dory Freeman, Wanling Xie, Erin G. Reid, Elizabeth Y. Chiao, Elad Sharon, Douglas B. Johnson, Ramya Ramaswami, Mark Bower, Brinda Emu, Thomas U. Marron, Toni K. Choueiri, Lindsey R. Baden, Kathryn Lurain, Guru P. Sonpavde, Abdul Rafeh Naqash
Publikováno v:
Journal of Clinical Oncology.
PURPOSE Compared with people living without HIV (PWOH), people living with HIV (PWH) and cancer have traditionally been excluded from immune checkpoint inhibitor (ICI) trials. Furthermore, there is a paucity of real-world data on the use of ICIs in P
Autor:
Dana Howard, Allan Rivlin, Philip Candilis, Neal W. Dickert, Claire Drolen, Benjamin Krohmal, Mark Pavlick, David Wendler
Publikováno v:
AJOB empirical bioethics, vol 13, iss 2
Current practice frequently fails to provide care consistent with the preferences of decisionally-incapacitated patients. It also imposes significant emotional burden on their surrogates. Algorithmic-based patient preference predictors (PPPs) have be
Autor:
Talal El Zarif, Amin Nassar, Elio Adib, Bailey Fitzgerald, Jiaming Huang, Tarek Mouhieddine, Taylor Nonato, Rana McKay, Mingjia Li, Arjun Mittra, Dwight Owen, Michael Lorentsen, Christopher Dittus, Nazli Dizman, Brinda Emu, Adewunmi Falohun, Noha Abdel-Wahab, Anand Bankapur, Alexandra Reed, Ryan Dobbs, Chul Kim, Aakriti Arora, Neil Shah, Edward El-Am, Elie Kozaily, Wassim Abdallah, Ahmad Al-Hader, Batool Abu Ghazal, Anwaar Saeed, Claire Drolen, Melissa Lechner, Javier Espinar, Caroline Nebhan, Douglas Johnson, Tarek Haykal, Michael Morse, Alessio Cortellini, David Pinato, Alessia Dalla Pria, Mark Bower, Evan Hall, Veli Bakalov, Nathan Bahary, Aarthi Rajkumar, Ankit Mangla, Vishal Shah, Parminder Singh, Frank Aboubakar Nana, Nerea Lopetegui Lia, Danai Dima, Pauline Funchain, Rabia Saleem, Rachel Woodford, Georgina Long AO, Alexander Menzies, Carlo Genova, Giulia Barletta, Sonam Puri, Vaia Florou, Dame Idossa, Paola Queirolo, Giuseppe Lamberti, Alfredo Addeo, Melissa Bersanelli, Dory Freeman, Wanling Xie, Ramya Ramaswami, Thomas Marron, Toni Choueiri, Kathryn Lurain, Lindsey Baden, Guru Sonpavde, Abdul Rafeh Naqash
Publikováno v:
Regular and Young Investigator Award Abstracts.
Publikováno v:
American Journal of Transplantation. 20:3631-3638
In November 2017, the donation service area (DSA) was removed as the primary unit of US donor lung allocation. Our primary objective was to evaluate the effect of this change on recipient characteristics, the use of pretransplant extracorporeal membr
Autor:
Talal El Zarif, Amin Nassar, Elio Adib, Jiaming Huang, Rana R. McKay, Ryan Dobbs, Nazli Dizman, Claire Drolen, Elie Kozaily, Anwaar Saeed, Caroline Nebhan, Michael Lorentsen, Javier Baena, Alessia Dalla Pria, Lindsey Baden, Ramya Ramaswami, Toni K. Choueiri, Kathryn Anne Lurain, Guru P. Sonpavde, Abdul Rafeh Naqash
Publikováno v:
Journal of Clinical Oncology. 40:2649-2649
2649 Background: PLWH and ca are inadequately represented in clinical trials evaluating ICI especially in the setting of low CD4 counts (ct) and elevated HIV viral loads (VL). We assembled an international cohort of PLWH and ca treated with ICI to ev
Autor:
Neal W. Dickert, Benjamin Krohmal, Claire Drolen, Allan Rivlin, Mark Pavlick, Philip Candilis, Dana Howard, David Wendler
Objective: Current practice frequently fails to provide care consistent with the preferences and values of decisionally-incapacitated, critically ill patients. It also imposes significant emotional burden on their surrogates. Algorithmic-based patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::100cf9be2bfe1a91c771bae32d04d346
https://doi.org/10.21203/rs.3.rs-480243/v1
https://doi.org/10.21203/rs.3.rs-480243/v1
Autor:
Claire, Drolen, Eric, Conklin, Stephen J, Hetterich, Aditi, Krishnamurthy, Gabriel A, Andrade, John L, Dimeglio, Maxwell I, Martin, Linh K, Tran, Glenn P A, Yap, Joel, Rosenthal, Elizabeth R, Young
Publikováno v:
Journal of the American Chemical Society. 140(32)
The metal-to-ligand charge transfer excited states of [Ru(bpy)(3)](2+) (bpy = 2,2′-bipyridine) may be deactivated via energy transfer or electron transfer with ferrocene derivatives in aqueous conditions. Stern–Volmer quenching analysis revealed
Autor:
Claire Drolen, William Senapedis, Trinayan Kashyap, Sharon Shacham, Irfana Muqbil, Thaddeus J. Unger, Amro Aboukameel, Christian Argueta, Michael Kauffman, Yosef Landesman, Asfar S. Azmi, Ramzi M. Mohammad, Margaret Lee, Boris Klebanov
Publikováno v:
Oncotarget
The nuclear export protein, exportin-1 (XPO1/CRM1), is overexpressed in many cancers and correlates with poor prognosis. Selinexor, a first-in-class Selective Inhibitor of Nuclear Export (SINE) compound, binds covalently to XPO1 and blocks its functi